Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model ; volume:7 ; number:1 ; day:14 ; month:2 ; year:2008 ; pages:1-10 ; date:12.2008
Molecular cancer ; 7, Heft 1 (14.2.2008), 1-10, 12.2008
- Urheber
-
Arnold, Alan A.
Aboukameel, Amro
Chen, Jianyong
Yang, Dajun
Wang, Shaomeng
Al-Katib, Ayad
Mohammad, Ramzi M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-7-20
- URN
-
urn:nbn:de:101:1-2021082319445052709016
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Arnold, Alan A.
- Aboukameel, Amro
- Chen, Jianyong
- Yang, Dajun
- Wang, Shaomeng
- Al-Katib, Ayad
- Mohammad, Ramzi M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rolle von Bcl-2, Bcl-xl und Mcl-1 für die Apoptoseresistenz und Chemoresistenz des Pankreaskarzinoms
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition
Bcl-XL but Not Bcl-2 is a potential target in medulloblastoma therapy
Regulation of Bcl-xL activity in apoptosis
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis
Dual inhibition of anti-apoptotic proteins BCL-XL and MCL-1 enhances cytotoxicity of Nasopharyngeal carcinoma cells
Photodynamic therapy combined with Bcl-2/Bcl-xL inhibition increases the Noxa/Mcl-1 ratio independent of usp9X and synergistically enhances apoptosis in glioblastoma
Rolle von Bcl-2, Bcl-xl und Mcl-1 für die Apoptoseresistenz und Chemoresistenz des Pankreaskarzinoms
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition
Bcl-XL but Not Bcl-2 is a potential target in medulloblastoma therapy
Regulation of Bcl-xL activity in apoptosis
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis
Dual inhibition of anti-apoptotic proteins BCL-XL and MCL-1 enhances cytotoxicity of Nasopharyngeal carcinoma cells
Photodynamic therapy combined with Bcl-2/Bcl-xL inhibition increases the Noxa/Mcl-1 ratio independent of usp9X and synergistically enhances apoptosis in glioblastoma
Rolle von Bcl-2, Bcl-xl und Mcl-1 für die Apoptoseresistenz und Chemoresistenz des Pankreaskarzinoms
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition
Bcl-XL but Not Bcl-2 is a potential target in medulloblastoma therapy
Regulation of Bcl-xL activity in apoptosis
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis
Dual inhibition of anti-apoptotic proteins BCL-XL and MCL-1 enhances cytotoxicity of Nasopharyngeal carcinoma cells